Literature DB >> 26133275

Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.

S Q Nagelkerke1, C E Tacke2, W B Breunis2, J Geissler1, J W R Sins2, B Appelhof3, T K van den Berg1, M de Boer1, T W Kuijpers1,2.   

Abstract

The human FCGR2/3 locus, containing five highly homologous genes encoding the major IgG receptors, shows extensive copy number variation (CNV) associated with susceptibility to autoimmune diseases. Having genotyped >4000 individuals, we show that all CNV at this locus can be explained by nonallelic homologous recombination (NAHR) of the two paralogous repeats that constitute the majority of the locus, and describe four distinct CNV regions (CNRs) with a highly variable prevalence in the population. Apart from CNV, NAHR events also created several hitherto unidentified chimeric FCGR2 genes. These include an FCGR2A/2C chimeric gene that causes a decreased expression of FcγRIIa on phagocytes, resulting in a decreased production of reactive oxygen species in response to immune complexes, compared with wild-type FCGR2A. Conversely, FCGR2C/2A chimeric genes were identified to lead to an increased expression of FCGR2C. Finally, a rare FCGR2B null-variant allele was found, in which a polymorphic stop codon of FCGR2C is introduced into one FCGR2B gene, resulting in a 50% reduction in protein expression. Our study on CNRs and the chimeric genes is essential for the correct interpretation of association studies on FCGR genes as a determinant for disease susceptibility, and may explain some as yet unidentified extreme phenotypes of immune-mediated disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26133275     DOI: 10.1038/gene.2015.25

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  24 in total

Review 1.  Segmental duplications: an 'expanding' role in genomic instability and disease.

Authors:  B S Emanuel; T H Shaikh
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

2.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

Authors:  Chiea Chuen Khor; Sonia Davila; Willemijn B Breunis; Yi-Ching Lee; Chisato Shimizu; Victoria J Wright; Rae S M Yeung; Dennis E K Tan; Kar Seng Sim; Jie Jin Wang; Tien Yin Wong; Junxiong Pang; Paul Mitchell; Rolando Cimaz; Nagib Dahdah; Yiu-Fai Cheung; Guo-Ying Huang; Wanling Yang; In-Sook Park; Jong-Keuk Lee; Jer-Yuarn Wu; Michael Levin; Jane C Burns; David Burgner; Taco W Kuijpers; Martin L Hibberd
Journal:  Nat Genet       Date:  2011-11-13       Impact factor: 38.330

3.  Evolutionary history of copy-number-variable locus for the low-affinity Fcγ receptor: mutation rate, autoimmune disease, and the legacy of helminth infection.

Authors:  Lee R Machado; Robert J Hardwick; Jennifer Bowdrey; Helen Bogle; Timothy J Knowles; Manuela Sironi; Edward J Hollox
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

4.  Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles.

Authors:  Joris van der Heijden; Willemijn B Breunis; Judy Geissler; Martin de Boer; Timo K van den Berg; Taco W Kuijpers
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

5.  FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer.

Authors:  K Tamura; C Shimizu; T Hojo; S Akashi-Tanaka; T Kinoshita; K Yonemori; T Kouno; N Katsumata; M Ando; K Aogi; F Koizumi; K Nishio; Y Fujiwara
Journal:  Ann Oncol       Date:  2010-11-25       Impact factor: 32.976

6.  Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura.

Authors:  Willemijn B Breunis; Edwin van Mirre; Marrie Bruin; Judy Geissler; Martin de Boer; Marjolein Peters; Dirk Roos; Masja de Haas; Harry R Koene; Taco W Kuijpers
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

7.  Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.

Authors:  Y H Lee; J D Ji; G G Song
Journal:  Lupus       Date:  2009-07       Impact factor: 2.911

8.  Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients.

Authors:  Ji-Yih Chen; Chin-Man Wang; Su-Wei Chang; Ching-Hui Cheng; Yeong-Jian Jan Wu; Jing-Chi Lin; Bing Yang; Huei-Huang Ho; Jianming Wu
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

9.  Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus.

Authors:  Michael Mueller; Paula Barros; Abigail S Witherden; Amy L Roberts; Zhou Zhang; Helmut Schaschl; Chack-Yung Yu; Matthew E Hurles; Catherine Schaffner; R Andres Floto; Laurence Game; Karyn Meltz Steinberg; Richard K Wilson; Tina A Graves; Evan E Eichler; H Terence Cook; Timothy J Vyse; Timothy J Aitman
Journal:  Am J Hum Genet       Date:  2012-12-20       Impact factor: 11.025

10.  FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity.

Authors:  Manuela Fanciulli; Penny J Norsworthy; Enrico Petretto; Rong Dong; Lorraine Harper; Lavanya Kamesh; Joanne M Heward; Stephen C L Gough; Adam de Smith; Alexandra I F Blakemore; Philippe Froguel; Catherine J Owen; Simon H S Pearce; Luis Teixeira; Loic Guillevin; Deborah S Cunninghame Graham; Charles D Pusey; H Terence Cook; Timothy J Vyse; Timothy J Aitman
Journal:  Nat Genet       Date:  2007-05-21       Impact factor: 38.330

View more
  17 in total

1.  FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.

Authors:  Amy K Erbe; Wei Wang; Jacob Goldberg; Mikayla Gallenberger; KyungMann Kim; Lakeesha Carmichael; Dustin Hess; Eneida A Mendonca; Yiqiang Song; Jacquelyn A Hank; Su-Chun Cheng; Sabina Signoretti; Michael Atkins; Alexander Carlson; James W Mier; David J Panka; David F McDermott; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2016-10-14       Impact factor: 12.531

2.  Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Annemieke G Laarhoven; Marrie C A Bruin; Barbera Veldhuisen; Sietse Q Nagelkerke; Taco W Kuijpers; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Masja de Haas
Journal:  Blood Adv       Date:  2019-07-09

3.  Systematic identification of genomic elements that regulate FCGR2A expression and harbor variants linked with autoimmune disease.

Authors:  Johanna Dahlqvist; Charles P Fulco; John P Ray; Thomas Liechti; Carl G de Boer; David J Lieb; Thomas M Eisenhaure; Jesse M Engreitz; Mario Roederer; Nir Hacohen
Journal:  Hum Mol Genet       Date:  2022-06-22       Impact factor: 5.121

4.  FCGR Genetic Variation in Two Populations From Ecuador Highlands-Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) Gene.

Authors:  Manuela Moraru; Adriana Perez-Portilla; Karima Al-Akioui Sanz; Alfonso Blazquez-Moreno; Antonio Arnaiz-Villena; Hugh T Reyburn; Carlos Vilches
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

5.  FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis.

Authors:  Jianming Wu; Yunfang Li; Weihua Guan; Kevin Viken; David M Perlman; Maneesh Bhargava
Journal:  Hum Genet       Date:  2016-04-08       Impact factor: 5.881

6.  Understanding the Genomic Structure of Copy-Number Variation of the Low-Affinity Fcγ Receptor Region Allows Confirmation of the Association of FCGR3B Deletion with Rheumatoid Arthritis.

Authors:  Raheleh Rahbari; Luciana W Zuccherato; German Tischler; Belinda Chihota; Hasret Ozturk; Sara Saleem; Eduardo Tarazona-Santos; Lee R Machado; Edward J Hollox
Journal:  Hum Mutat       Date:  2017-02-15       Impact factor: 4.878

Review 7.  Neonatal Immune Incompatibilities between Newborn and Mother.

Authors:  Borros Arneth
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

8.  Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.

Authors:  Khiyam Hussain; Chantal E Hargreaves; Tania F Rowley; Joshua M Sopp; Kate V Latham; Pallavi Bhatta; John Sherington; Rona M Cutler; David P Humphreys; Martin J Glennie; Jonathan C Strefford; Mark S Cragg
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

9.  Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation.

Authors:  Nathaniel Washburn; Robin Meccariello; Jay Duffner; Kristen Getchell; Kimberly Holte; Thomas Prod'homme; Karunya Srinivasan; Robert Prenovitz; Jonathan Lansing; Ishan Capila; Ganesh Kaundinya; Anthony M Manning; Carlos J Bosques
Journal:  Mol Cell Proteomics       Date:  2018-12-17       Impact factor: 5.911

10.  FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.

Authors:  Louise W Treffers; Michel van Houdt; Christine W Bruggeman; Marieke H Heineke; Xi Wen Zhao; Joris van der Heijden; Sietse Q Nagelkerke; Paul J J H Verkuijlen; Judy Geissler; Suzanne Lissenberg-Thunnissen; Thomas Valerius; Matthias Peipp; Katka Franke; Robin van Bruggen; Taco W Kuijpers; Marjolein van Egmond; Gestur Vidarsson; Hanke L Matlung; Timo K van den Berg
Journal:  Front Immunol       Date:  2019-01-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.